TY - JOUR
T1 - We Just Never Have Enough Time" Clinician Views of Lung Cancer Screening Processes and Implementation
AU - Cmelzer, Anne
AU - Golden, Sara E.
AU - Ono, Sarah S.
AU - Datta, Santanu
AU - Triplette, Matthew
AU - Slatore, Christopherg G.
N1 - Publisher Copyright:
© 2020 American Thoracic Society. All rights reserved.
PY - 2020/10
Y1 - 2020/10
N2 - Rationale: Despite a known mortality benefit, lung cancer screening (LCS) implementation has been unexpectedly slow. New programs face barriers to implementation, which may include lack of clinician engagement or beliefs that the intervention is not beneficial. Objectives: To evaluate diverse clinician perspectives on their views of LCS and their experience with LCS implementation and processes. Methods: We performed a qualitative study of clinicians participating in LCS. Clinicians were drawn from three medical centers and represented diverse specialties and practice settings. All participants practiced at sites with formal LCS programs. We performed semistructured interviews with probes designed to elicit opinions of LCS, perceived evidence gaps, and recommendations for improvements. Transcribed interviews were iteratively reviewed and coded using directed content analysis. Results: Participants (N= 24) included LCS coordinators, pulmonologists, physician and nonphysician primary care providers (PCPs), a surgeon, and a radiologist. Most clinicians expressed their belief that the evidence supporting LCS was adequate to support clinical adoption, though most PCPs had little direct knowledge and based their decisions on local recommendations or endorsement by the U.S. Preventive Services Task Force. Many PCPs endorsed lack of knowledge of eligibility requirements and screening strategy (e.g., annual while eligible). Clinicians with more LCS knowledge, including several PCPs, identified a number of gaps in the current evidence that tempered enthusiasm, including unclear ideal screening interval, populations with high cancer risk that do not qualify under the U.S. Preventive Services Task Force guidelines, indications to stop screening, and the role of serious comorbidities. Support for centralized programs and LCS coordinators was strong but not uniform. Clinicians were frustrated by time limitations during a patient encounter, costs to the patient, and issues with insurance coverage. Many gaps in informatics support were identified. Clinicians recommended working to improve informatics support, continuing to clarify clinician responsibilities, and working on increasing public awareness of LCS. Conclusions: Despite working within programs that have adopted many recommended care processes to support LCS, clinicians identified a number of issues in providing high-quality LCS. Many of these issues are best addressed by improved support of LCS within the electronic health record and continued education of staff and patients.
AB - Rationale: Despite a known mortality benefit, lung cancer screening (LCS) implementation has been unexpectedly slow. New programs face barriers to implementation, which may include lack of clinician engagement or beliefs that the intervention is not beneficial. Objectives: To evaluate diverse clinician perspectives on their views of LCS and their experience with LCS implementation and processes. Methods: We performed a qualitative study of clinicians participating in LCS. Clinicians were drawn from three medical centers and represented diverse specialties and practice settings. All participants practiced at sites with formal LCS programs. We performed semistructured interviews with probes designed to elicit opinions of LCS, perceived evidence gaps, and recommendations for improvements. Transcribed interviews were iteratively reviewed and coded using directed content analysis. Results: Participants (N= 24) included LCS coordinators, pulmonologists, physician and nonphysician primary care providers (PCPs), a surgeon, and a radiologist. Most clinicians expressed their belief that the evidence supporting LCS was adequate to support clinical adoption, though most PCPs had little direct knowledge and based their decisions on local recommendations or endorsement by the U.S. Preventive Services Task Force. Many PCPs endorsed lack of knowledge of eligibility requirements and screening strategy (e.g., annual while eligible). Clinicians with more LCS knowledge, including several PCPs, identified a number of gaps in the current evidence that tempered enthusiasm, including unclear ideal screening interval, populations with high cancer risk that do not qualify under the U.S. Preventive Services Task Force guidelines, indications to stop screening, and the role of serious comorbidities. Support for centralized programs and LCS coordinators was strong but not uniform. Clinicians were frustrated by time limitations during a patient encounter, costs to the patient, and issues with insurance coverage. Many gaps in informatics support were identified. Clinicians recommended working to improve informatics support, continuing to clarify clinician responsibilities, and working on increasing public awareness of LCS. Conclusions: Despite working within programs that have adopted many recommended care processes to support LCS, clinicians identified a number of issues in providing high-quality LCS. Many of these issues are best addressed by improved support of LCS within the electronic health record and continued education of staff and patients.
KW - Control
KW - Lung cancer
KW - Prevention
UR - http://www.scopus.com/inward/record.url?scp=85091007244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091007244&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.202003-262OC
DO - 10.1513/AnnalsATS.202003-262OC
M3 - Article
C2 - 32497437
AN - SCOPUS:85091007244
SN - 2329-6933
VL - 17
SP - 1264
EP - 1272
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
IS - 10
ER -